1. Piet AH,
Hulshof MC,
Pieters BR,
Pos FJ,
de Reijke TM,
Koning CC.
Clinical results of a concomitant boost radiotherapy technique for muscle-invasive bladder cancer.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft [et al].
2008;184(6):313-8.
2. Yavuz AA,
Yavuz MN,
Ozgur GK,
Colak F,
Ozyavuz R,
Cimsitoglu E,
et al.
Accelerated superfractionated radiotherapy with concomitant boost for invasive bladder cancer.
International journal of radiation oncology,
biology,
physics.
2003;56(3):734-45.
3. Cowan RA,
McBain CA,
Ryder WD,
Wylie JP,
Logue JP,
Turner SL,
et al.
Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy.
International journal of radiation oncology,
biology,
physics.
2004;59(1):197-207.
4. Pos FJ,
Hulshof M,
Lebesque J,
Lotz H,
van Tienhoven G,
Moonen L,
et al.
Adaptive radiotherapy for invasive bladder cancer: a feasibility study.
International journal of radiation oncology,
biology,
physics.
2006;64(3):862-8.
5. Pos F,
Bex A,
Dees-Ribbers HM,
Betgen A,
van Herk M,
Remeijer P.
Lipiodol injection for target volume delineation and image guidance during radiotherapy for bladder cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
2009;93(2):364-7.
6. Kong V,
Rosewall T,
Chen S,
Craig T,
Bristow R,
Milosevic M,
et al.
Deriving patient-specific planning target volume for partial bladder image guided radiation therapy.
Practical radiation oncology.
2014;4(5):323-9.